Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ADAMTS7 pseudogene 5 (ADAMTS7P5) is a pseudogene—an inactive genomic sequence derived from the functional *ADAMTS7* gene. It does not encode an active protein and is not implicated in biological processes or disease mechanisms. Its existence can pose a technical challenge to genetic studies on *ADAMTS7* due to high sequence similarity, which may interfere with variant discovery in short-read sequencing data[3]. In contrast, the functional *ADAMTS7* gene encodes an extracellular metalloproteinase that regulates vascular smooth muscle cell migration, cartilage degradation, and is implicated in coronary artery disease and arthritis[1][3][4][5]. ADAMTS7P5 should not be considered a drug target, receptor, biomarker, or disease-causing gene.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ADAMTS7 pseudogene 5 (ADAMTS7P5).